Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
---|
01/03/2008 | WO2006119115A3 Anti-il-6 antibodies, compositions, methods and uses |
01/03/2008 | WO2005032476A3 Methods and compositions for cpg15-2 |
01/03/2008 | WO2003085085A3 Superior molecular vaccine linking the translocation domain of a bacterial toxin to an antigen |
01/03/2008 | US20080005812 Expression cassettes; cells, seeds, plants |
01/03/2008 | US20080005811 Pufa polyketide synthase systems and uses thereof |
01/03/2008 | US20080005808 transgenic plants transformed with nucleotide sequence coding for vesicle transport stress-related polypeptides or resulting in gene expression of increased growth and/or increased drought resistance |
01/03/2008 | US20080004713 Scaffold-free self-organized 3d synthetic tissue |
01/03/2008 | US20080004368 biocompatible, bioresorbable, injectable, in-situ hardening scaffold for tissue engineering; self-crosslinkable and photocrosslinkable; better mechanical strength and self-crosslinking characteristics than polycaprolactone fumarate homopolymer; bone regeneration; hydroxyapatite filler |
01/03/2008 | US20080004355 Method for Inhibiting Telomerase Activity and an Agent for Inhibiting the Same |
01/03/2008 | US20080004282 Compositions and methods for modulating gated ion channels |
01/03/2008 | US20080004273 Inhibitors of VEGF and HGF receptor signaling; treating cell proliferative diseases; N-(4-(6,7-Dimethoxyquinolin-4-yloxy)-3-fluorophenyl)-2-oxo-1-phenylpyrrolidine-3-carboxamide |
01/03/2008 | US20080004271 Inhibitors of TNFalpha, PDE4 and B-RAF, compositions thereof and methods of use therewith |
01/03/2008 | US20080004263 Ligands of Follicle Stimulating Hormone Receptor and Methods of Use Thereof |
01/03/2008 | US20080004233 Delta-Tocotrienol Treatment and Prevention of Pancreatic Cancer |
01/03/2008 | US20080004231 Disease-Associated Protein |
01/03/2008 | US20080004229 Methods and Compositions Related to Skcg-1, a Tumor Suppressor |
01/03/2008 | US20080004228 New Expression Tools for Multiprotein Applications |
01/03/2008 | US20080004211 Inhibitors of Amyloid Fibril Formation and Uses Thereof |
01/03/2008 | US20080004206 Albumin fusion proteins |
01/03/2008 | US20080003683 Ce7-specific redirected immune cells |
01/03/2008 | US20080003681 Methods for altering cellular susceptibility to infection |
01/03/2008 | US20080003680 plants and plant cells comprising of functional mammalian enzyme providing N-glycan biosynthesis that is normally not present in plants, for example mammalian beta 1,4-galactosyltransferase; glycoprotein processing in transgenic plants used as cost efficient and contamination safe factories |
01/03/2008 | US20080003679 Cell culture medium |
01/03/2008 | US20080003678 Cell separation chip and cell culturing method using the same |
01/03/2008 | US20080003677 Three dimensional vaginal tissue model containing immune cells |
01/03/2008 | US20080003676 Growth of embryonic stem cells |
01/03/2008 | US20080003675 Methods and compositions for identifying morphogen analogs |
01/03/2008 | US20080003674 ERYTHROID CELLS PRODUCING ADULT-TYPE Beta-HEMOGLOBIN GENERATED FROM HUMAN EMBRYONIC STEM CELLS |
01/03/2008 | US20080003659 Reversible Binding Surface |
01/03/2008 | US20080003637 Methods for Separating Hepatic, Endothelial, or Hematopoietic Progenitor Cells From Cell Populations |
01/03/2008 | US20080003634 Extended Primary Retinal Cell Culture and Stress Models, and Methods of Use |
01/03/2008 | US20080003614 Mitochondrial anti-viral signaling protein; activates the NF- kappa B and IRF families of transcription factors to induce interferons in viral infected cells to clear viral infection |
01/03/2008 | US20080003596 Vector and method for detecting the change in transcription amount |
01/03/2008 | US20080003570 Translation enhancer elements of genes encoding human Tau protein and human alpha-synuclein protein |
01/03/2008 | US20080003560 Tailor-made pluripotent stem cell and use of the same |
01/03/2008 | US20080003243 Oral Anti-Protozoiasis Vaccines Based on Transgenic Plants |
01/03/2008 | US20080003229 the polypeptide induces an immune response directed both against the immunodominant region and against the protein of the host; vaccine |
01/03/2008 | US20080003227 Acetyl CoA Carboxylase Splice Variant and Uses Thereof |
01/03/2008 | US20080003224 Compositions and methods for treating haematological proliferative disorders |
01/03/2008 | US20080003223 Babesia canis vaccine |
01/03/2008 | US20080003221 Compositions and methods for treating inflammatory lung disease |
01/03/2008 | US20080003218 Anti-IgE antibodies |
01/03/2008 | US20080003212 ATP Diphosphohydrolase (CD39) Gene Therapy for Inflammatory or Thrombotic Conditions for Transplantation and Means Therefor |
01/03/2008 | US20080003210 Non-human primate receptor tyrosine kinases |
01/03/2008 | US20080003206 ABCB5 positive mesenchymal stem cells as immunomodulators |
01/03/2008 | US20080003202 Modified interferon-beta (IFN-beta) polypeptides |
01/03/2008 | US20080003200 Tissue selective binding for prostate and/or bone cancer, or adipose tissue; apoptosis induction; diagnosis, prognosis; staging metastatic cancer |
01/03/2008 | US20080000405 S-adenosylmethionine Synthetase Expression Elements Identified from Arabidopsis thaliana |
01/03/2008 | DE102006020444A1 Transgenic mesenchymal stem cells stably expressing tumor necrosis factor-related apoptosis-inducing ligand, e.g. useful for treating tumors |
01/03/2008 | DE102004017483B4 Verfahren zur Isolierung adulter Stammzellen aus differenziertem Gewebe Method for the isolation of adult stem cells from differentiated tissue |
01/03/2008 | CA2692445A1 Novel cellular glycan compositions |
01/03/2008 | CA2690985A1 Differentiation of stem cells from umbilical cord matrix into hepatocyte lineage cells |
01/03/2008 | CA2689241A1 Matrix and method for isolation of hepatic progenitor cells |
01/03/2008 | CA2656970A1 Transgenic crop plants with improved stress tolerance |
01/03/2008 | CA2656551A1 Methods for altering cellular susceptibility to infection |
01/03/2008 | CA2656243A1 Nonalcoholic steatohepatitis model animal and fatty liver model animal |
01/03/2008 | CA2656228A1 Composition for nucleic-acid transfection |
01/03/2008 | CA2656107A1 Cancer therapy using bcl-xl-specific sina |
01/03/2008 | CA2655874A1 Antibody molecules which bind human il-17 |
01/03/2008 | CA2655725A1 Improvements in or relating to organic compounds |
01/03/2008 | CA2654656A1 Production of fermentation products in biofilm reactors using microorganisms immobilised on sterilised granular sludge |
01/03/2008 | CA2626809A1 Method of culturing mesenchymal stem cells |
01/02/2008 | EP1873527A1 Method for identifying CRMP modulators |
01/02/2008 | EP1873259A1 RNA interference is mediated by 21 and 22nt small RNAs |
01/02/2008 | EP1873245A1 Interleukin-8 homologous polypeptides and therapeutic uses thereof |
01/02/2008 | EP1873239A1 Gene capable of controlling differentiation/growth of plant, and use of the same |
01/02/2008 | EP1873237A1 Growth of embryonic stem cells |
01/02/2008 | EP1873236A1 Quality control method for cells cultivated in a culture medium with SERPINA1 and MMP-3 as quality markers for chondrogenic potency of chondrocytes |
01/02/2008 | EP1871886A2 Compositions and methods for the diagnosis and treatment of tumor |
01/02/2008 | EP1871882A1 Antigen binding molecules directed to mcsp and having increased fc receptor binding affinity and effector function |
01/02/2008 | EP1871873A1 Cytotrophoblast stem cell |
01/02/2008 | EP1871872A1 Method for activating cd8 t cells |
01/02/2008 | EP1871871A1 Method for activating cd4 t cells |
01/02/2008 | EP1871870A2 Method for enriching rare cell subpopulations from blood |
01/02/2008 | EP1871869A1 Method of inducing embryonic stem cells into pancreatic cells |
01/02/2008 | EP1871425A2 Defective sindbis viral vectors |
01/02/2008 | EP1871402A2 Fruit cell culture extract for treating inflammation |
01/02/2008 | EP1796592A4 Method for in situ repair of injured, damaged, diseased or aged articular cartilage using neo-cartilage constructs and a method for preparation thereof |
01/02/2008 | EP1660646A4 Thermostable peroxide-driven cytochrome p450 oxygenase variants and methods of use |
01/02/2008 | EP1641491B1 Increased t-cell tumor infiltration by mutant light |
01/02/2008 | EP1585954A4 Mammalian sweet and amino acid heterodimeric taste receptors |
01/02/2008 | EP1425397B1 Modified cry3a toxins and nucleic acid sequences coding therefor |
01/02/2008 | EP1317476B1 Reagents for cell selection and methods of use |
01/02/2008 | EP1303606B1 Regulation of gene expression using single-chain, monomeric, ligand dependent polypeptide switches |
01/02/2008 | EP1278868B1 Mutated form of arginine deiminase |
01/02/2008 | EP1238056B1 SEROLOGICAL DIAGNOSTIC METHOD WITH i RICKETTSIA PULICIS /i BACTERIUM |
01/02/2008 | EP1100870B1 Improvement of cardiac function by mesenchymal stem cell transplantation |
01/02/2008 | EP1028978B1 Methods of preparing glycosylated antibodies and antibody fragments having reactive ketone groups |
01/02/2008 | EP1005365B1 Epitopes of an extracellular antigen |
01/02/2008 | EP0942934B1 Receptor tyrosine kinase genes |
01/02/2008 | EP0920514B1 Targeting adenovirus with use of constrained peptide motifs |
01/02/2008 | EP0863987B1 Vectors and methods for gene transfer to cells |
01/02/2008 | CN101098961A Inactive ca2+/calmodulin-dependent protein kinase ii-alpha knockin animal and knockin cell of the same |
01/02/2008 | CN101098892A Antibodies against IL-13 receptor alpha 1 and uses thereof |
01/02/2008 | CN101098882A Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis |
01/02/2008 | CN101096684A Zinc finger protein DPZF gene knock-out mice model and its usage |
01/02/2008 | CN101096673A Method for carrying out agrobacterium tumefaciens mediated banana genes by employing liquid co-culture system |
01/02/2008 | CN101096657A Preparation method of monoclonal antibody against Asial type foot-and-mouth disease virus and usage |
01/02/2008 | CN101096656A Helicobacter pylori recombinant VacA monoclonal antibody and uses thereof |
01/02/2008 | CN101096655A Process for cultivating recombinant human tectotype fibrinolytic enzyme activator TNK mutant with micro-carrier |